Hennessy Advisors Inc’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-13,643
Closed -$163K 273
2021
Q1
$163K Buy
13,643
+393
+3% +$4.46K 0.01% 261
2020
Q4
$120K Sell
13,250
-1,091
-8% -$8.44K 0.01% 262
2020
Q3
$87K Buy
+14,341
New +$109K 0.01% 257
2017
Q1
Sell
-350,200
Closed -$3.79M 347
2016
Q4
$3.79M Sell
350,200
-18,900
-5% -$252K 0.11% 155
2016
Q3
$6.03M Sell
369,100
-40,000
-10% -$563K 0.17% 115
2016
Q2
$3.9M Sell
409,100
-13,700
-3% -$149K 0.12% 155
2016
Q1
$5.94M Buy
+422,800
New +$4.38M 0.18% 102

Other funds holding NPTN

Hennessy Advisors Inc's NPTN Position: Q2 2021 in Review

Hennessy Advisors Inc sold out of NEOPHOTONICS CORP (NPTN) in Q2 2021, closing a stake of 13,643 shares — an estimated $163K sold.

Hennessy Advisors Inc first reported a position in NPTN in Q1 2016 and held it in 7 quarters. The position peaked at $6.03M in Q3 2016. 138 funds tracked by Wall St. Rank hold NPTN as of Q2 2021.

  • Hennessy Advisors Inc reported no remaining NEOPHOTONICS CORP position as of Q2 2021 after selling out during the quarter.
  • Hennessy Advisors Inc sold 13,643 NEOPHOTONICS CORP shares in Q2 2021, an estimated $163K.
  • Hennessy Advisors Inc first reported a position in NEOPHOTONICS CORP in Q1 2016 and held it in 7 quarters.
  • Hennessy Advisors Inc's NEOPHOTONICS CORP position peaked at $6.03M in Q3 2016.
  • 138 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q2 2021.

Based on Hennessy Advisors Inc's 13F filing for Q2 2021, filed 28 Jul 2021.